valley ranch
Garden Master
- Joined
- Dec 22, 2014
- Messages
- 5,742
- Reaction score
- 5,724
- Points
- 367
Margaret Miller, U.S. FDA/NCTR
Name:
Miller, Margaret
Job Title:
Associate Director
Margaret Ann Miller received her Ph.D. in Endocrinology-Reproductive Physiology from the University of Wisconsin-Madison in 1981. Following her degree she was a postdoctoral fellow at the University of Illinois, Champaign-Urbana, in the laboratory of Dr. Benita Katzenellenbogen, where she conducted research on the estrogen receptor. In 1985, Dr. Miller accepted a position at Monsanto Agricultural Company, where she supervised a laboratory supporting the research and clinical studies needed for the approval of recombinant products, including bovine somatotropin. Margaret prepared the text discribing the product safty to be supplied to the goverment.
In 1989, Dr. Miller joined the United States Food and Drug Administration (FDA) in the Division of Toxicology, Office of New Animal Drug Evaluation in the Center for Veterinary Medicine (CVM). She held several positions within the CVM including Deputy Director for Human Food Safety in the Office of New Animal Drug Evaluation. She was given the responsibility to evaluate the report from Monsanto that she had written. In 1999, Dr. Miller joined FDA’s Office of Women’s Health as the Manager of Science Programs. In this position she initiated several successful research initiatives aimed at promoting the health of women. She recently completed a two year detailat the World Health Organization, where she worked on Food Safety. Dr. Miller is currently the Associate Director of Regulatory Activities in the Washington Office of the National Center for Toxicological Research where she coordinates activities between the Center and Headquarters.
Margaret Miller, a former Monsanto research scientist working on the rBGH safety studies until 1989, joined the FDA in the area of New Animal Drug Evaluation. She ended up reviewing her own research and increasing the level of allowable antibodies in animals by 100 times while at the FDA.
Name:
Miller, Margaret
Job Title:
Associate Director
Margaret Ann Miller received her Ph.D. in Endocrinology-Reproductive Physiology from the University of Wisconsin-Madison in 1981. Following her degree she was a postdoctoral fellow at the University of Illinois, Champaign-Urbana, in the laboratory of Dr. Benita Katzenellenbogen, where she conducted research on the estrogen receptor. In 1985, Dr. Miller accepted a position at Monsanto Agricultural Company, where she supervised a laboratory supporting the research and clinical studies needed for the approval of recombinant products, including bovine somatotropin. Margaret prepared the text discribing the product safty to be supplied to the goverment.
In 1989, Dr. Miller joined the United States Food and Drug Administration (FDA) in the Division of Toxicology, Office of New Animal Drug Evaluation in the Center for Veterinary Medicine (CVM). She held several positions within the CVM including Deputy Director for Human Food Safety in the Office of New Animal Drug Evaluation. She was given the responsibility to evaluate the report from Monsanto that she had written. In 1999, Dr. Miller joined FDA’s Office of Women’s Health as the Manager of Science Programs. In this position she initiated several successful research initiatives aimed at promoting the health of women. She recently completed a two year detailat the World Health Organization, where she worked on Food Safety. Dr. Miller is currently the Associate Director of Regulatory Activities in the Washington Office of the National Center for Toxicological Research where she coordinates activities between the Center and Headquarters.
Margaret Miller, a former Monsanto research scientist working on the rBGH safety studies until 1989, joined the FDA in the area of New Animal Drug Evaluation. She ended up reviewing her own research and increasing the level of allowable antibodies in animals by 100 times while at the FDA.
